<VariationArchive VariationID="157570" VariationName="NM_201631.4(TGM5):c.640del (p.Leu214fs)" VariationType="Deletion" Accession="VCV000157570" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-30" DateCreated="2016-10-02" MostRecentSubmission="2020-01-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="167432" VariationID="157570">
      <GeneList>
        <Gene Symbol="TGM5" FullName="transglutaminase 5" GeneID="9333" HGNC_ID="HGNC:11781" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q15.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="43232590" stop="43266928" display_start="43232590" display_stop="43266928" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="43524792" stop="43559054" display_start="43524792" display_stop="43559054" Strand="-" />
          </Location>
          <OMIM>603805</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_201631.4(TGM5):c.640del (p.Leu214fs)</Name>
      <CanonicalSPDI>NC_000015.10:43253549:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q15.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="43253550" stop="43253550" display_start="43253550" display_stop="43253550" variantLength="1" positionVCF="43253549" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="43545748" stop="43545748" display_start="43545748" display_stop="43545748" variantLength="1" positionVCF="43545747" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>L132fs</ProteinChange>
      <ProteinChange>L214fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.43253550del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.43253550del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.43545748del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.43545748del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016124.1" sequenceAccession="NG_016124" sequenceVersion="1" change="g.18308del">
            <Expression>NG_016124.1:g.18308del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004245.4" sequenceAccession="NM_004245" sequenceVersion="4" change="c.394del">
            <Expression>NM_004245.4:c.394del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004236.1" sequenceAccession="NP_004236" sequenceVersion="1" change="p.Leu132fs">
            <Expression>NP_004236.1:p.Leu132fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_201631.4" sequenceAccession="NM_201631" sequenceVersion="4" change="c.640del" MANESelect="true">
            <Expression>NM_201631.4:c.640del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_963925.2" sequenceAccession="NP_963925" sequenceVersion="2" change="p.Leu214fs">
            <Expression>NP_963925.2:p.Leu214fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA170982" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603805.0005" DB="OMIM" />
        <XRef Type="rs" ID="606231277" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_201631.4(TGM5):c.640del (p.Leu214fs) AND Acral peeling skin syndrome" Accession="RCV000144914" Version="4">
        <ClassifiedConditionList TraitSetID="1673">
          <ClassifiedCondition DB="MedGen" ID="C1853354">Acral peeling skin syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_201631.4(TGM5):c.640del (p.Leu214fs) AND Peeling skin syndrome 1" Accession="RCV000989297" Version="1">
        <ClassifiedConditionList TraitSetID="6503">
          <ClassifiedCondition DB="MedGen" ID="C1849193">Peeling skin syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-05-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-05-28" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-10-02" MostRecentSubmission="2020-01-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22622422</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6503" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3776" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED</ElementValue>
                <XRef Type="MIM" ID="270300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peeling skin syndrome 1</ElementValue>
                <XRef ID="MONDO:0024548" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peeling skin syndrome, noninflammatory type A (subtype)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peeling skin syndrome, inflammatory type B (subtype)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peeling skin syndrome type B</ElementValue>
                <XRef ID="MONDO:0024548" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">KERATOLYSIS EXFOLIATIVA CONGENITA</ElementValue>
                <XRef Type="MIM" ID="270300" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PSS1</ElementValue>
                <XRef Type="MIM" ID="270300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17259" />
                <XRef ID="17259" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="263543" DB="Orphanet" />
              <XRef ID="263553" DB="Orphanet" />
              <XRef ID="C1849193" DB="MedGen" />
              <XRef ID="MONDO:0024548" DB="MONDO" />
              <XRef Type="MIM" ID="270300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1673" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3777" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Acral peeling skin syndrome</ElementValue>
                <XRef ID="MONDO:0012345" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peeling skin syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peeling skin syndrome, acral type (subtype)</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PSS2</ElementValue>
                <XRef Type="MIM" ID="609796" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">APSS</ElementValue>
                <XRef Type="MIM" ID="609796" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12863" />
                <XRef ID="12863" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some instances) that results in non-scarring blisters and erosions caused by minor mechanical trauma. EBS is distinguished from other types of epidermolysis bullosa (EB) or non-EB skin fragility syndromes by the location of the blistering in relation to the dermal-epidermal junction. In EBS, blistering occurs within basal keratinocytes. The severity of blistering ranges from limited to hands and feet to widespread involvement. Additional features can include hyperkeratosis of the palms and soles (keratoderma), nail dystrophy, milia, and hyper- and/or hypopigmentation. Rare EBS subtypes have been associated with additional clinical features including pyloric atresia, muscular dystrophy, cardiomyopathy, and/or nephropathy.</Attribute>
                <XRef ID="NBK1369" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301543</ID>
                <ID Source="BookShelf">NBK1369</ID>
              </Citation>
              <XRef ID="263534" DB="Orphanet" />
              <XRef ID="C1853354" DB="MedGen" />
              <XRef ID="MONDO:0012345" DB="MONDO" />
              <XRef Type="MIM" ID="609796" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="339296" SubmissionDate="2016-09-27" DateLastUpdated="2016-10-02" DateCreated="2014-11-10">
        <ClinVarSubmissionID localKey="603805.0005_PEELING SKIN SYNDROME 2" title="TGM5, 1-BP DEL, 640C_PEELING SKIN SYNDROME 2" />
        <ClinVarAccession Accession="SCV000191916" DateUpdated="2016-10-02" DateCreated="2014-11-10" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 1-year-old Italian patient with acral peeling skin syndrome (PSS2; 609796), Pigors et al. (2012) identified compound heterozygosity for 2 frameshift mutations in the TGM5 gene: a 1-bp deletion (c.640delC) in exon 5, causing a frameshift predicted to result in premature termination (Leu214CysfsTer15) in the catalytic core domain, and a deletion/insertion mutation (c.1811_1815delinsTCCTTCA; 603805.0006) in exon 11, causing a frameshift predicted to result in premature termination (Ser604IlefsTer9) in the beta-barrel-1 domain. The 1-bp deletion was also detected in compound heterozygosity with the recurrent G113C mutation (603805.0001) in a 12-year-old German patient. The unaffected parents from both families were each heterozygous for 1 of the mutations carried by their offspring.</Attribute>
              <Citation>
                <ID Source="PubMed">22622422</ID>
              </Citation>
              <XRef DB="OMIM" ID="609796" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TGM5" />
          </GeneList>
          <Name>TGM5, 1-BP DEL, 640C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 640C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603805.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEELING SKIN SYNDROME 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2245365" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-11" DateCreated="2020-01-11">
        <ClinVarSubmissionID localKey="NC_000015.9:g.43545748delG|OMIM:270300" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001139562" DateUpdated="2020-01-11" DateCreated="2020-01-11" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TGM5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.43545748delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="270300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="339296" TraitType="Disease" MappingType="Name" MappingValue="PEELING SKIN SYNDROME 2" MappingRef="Preferred">
        <MedGen CUI="C1853354" Name="Acral peeling skin syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2245365" TraitType="Disease" MappingType="XRef" MappingValue="270300" MappingRef="OMIM">
        <MedGen CUI="C1849193" Name="Peeling skin syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

